No takes yet. Share an insight, caveat, or question.
Review demonstrates reduced coronary heart disease risk with statin-mediated LDL lowering in existing disease, suggesting benefits from further lipid modification.
Steven M. Haffner (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: